Bank7 Corp plans sale of 5,049 common shares

Bank7 Corp. (BSVN) plans a broker-assisted sale of 5,049 shares of common stock through Stifel Nicolaus & Company Inc., with an aggregate market value of $249,957.00, on or after July 21, 2026 on Nasdaq.

Rhea-AI Filing Summary

Bank7 Corp. (BSVN) plans a broker-assisted sale of 5,049 shares of common stock through Stifel Nicolaus & Company Inc., with an aggregate market value of $249,957.00, on or after July 21, 2026 on Nasdaq. The filing notes that the shares relate to a stock option exercise for 1,250 shares dated January 4, 2021, and restricted stock awards of 2,751 shares dated February 15, 2025 and 1,048 shares dated December 16, 2025, all granted by the issuer as equity compensation. The company reports 9,519,335 shares of common stock outstanding.

Key Figures

Shares to be sold: 5,049 shares Aggregate market value: $249,957.00 Shares outstanding: 9,519,335 shares +3 more

6 metrics

Shares to be sold 5,049 shares Common stock proposed for sale on or after July 21, 2026

Aggregate market value $249,957.00 Total market value of 5,049 common shares to be sold

Shares outstanding 9,519,335 shares Common stock outstanding as reported in the notice

Option exercise shares 1,250 shares Common stock from stock option exercise dated January 4, 2021

Restricted stock award (Feb 15, 2025) 2,751 shares Restricted stock granted as equity compensation by issuer

Restricted stock award (Dec 16, 2025) 1,048 shares Restricted stock granted as equity compensation by issuer

Key Terms

Stock Option Exercise, Restricted Stock, Equity Compensation

3 terms

Stock Option Exercise financial

"Common Stock | 01/04/2021 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Common Stock | 02/15/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Equity Compensation financial

"12/16/2025 | Restricted Stock | Issuer | | | 1048 | 12/16/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being proposed for Bank7 Corp. (BSVN)?

The filer plans to sell 5,049 shares of Bank7 Corp. common stock, with an aggregate market value of $249,957.00, through Stifel Nicolaus & Company Inc. on or after July 21, 2026.

Which broker will handle the planned Bank7 Corp. (BSVN) share sale?

The proposed sale of 5,049 common shares of Bank7 Corp., valued at $249,957.00, is to be executed through Stifel Nicolaus & Company Inc. at 501 N Broadway, St. Louis, Missouri.

How many Bank7 Corp. (BSVN) shares are outstanding according to this filing?

The company reports 9,519,335 shares of Bank7 Corp. common stock outstanding. This figure provides context for the planned sale of 5,049 shares under the current notice.

What is the source of the Bank7 Corp. (BSVN) shares to be sold?

The shares derive from a stock option exercise of 1,250 shares dated January 4, 2021 and restricted stock awards totaling 3,799 shares dated February 15, 2025 and December 16, 2025, all granted as equity compensation by the issuer.

On which market will the Bank7 Corp. (BSVN) shares be sold?

The proposed 5,049-share sale of Bank7 Corp. common stock, valued at $249,957.00, is indicated for trading on the Nasdaq market on or after July 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/21/2026 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001752262
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bank7 Corp.
SEC File Number	001-38656
Address of Issuer	1039 NW 63RD STREET OKLAHOMA CITY OKLAHOMA 73116
Phone	405-810-8600
Name of Person for Whose Account the Securities are To Be Sold	Estes Jason E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	5049	249957.00	9519335	07/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/04/2021	Stock Option Exercise	Issuer			1250	07/21/2026	Cash
Common Stock	02/15/2025	Restricted Stock	Issuer			2751	02/15/2025	Equity Compensation
Common Stock	12/16/2025	Restricted Stock	Issuer			1048	12/16/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Jason Estes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)